Gluskin Sheff & Assoc Inc Abbott Laboratories Transaction History

Gluskin Sheff & Assoc Inc

$788 Million
Q2 2025

A detailed history of Gluskin Sheff & Assoc Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 46,856 shares of ABT stock, worth $6.31 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

46,856

Previous 47,832 2.04%

Holding current value

$6.31 Million

Previous $6.34 Million 0.44%

% of portfolio

0.81%

Previous 0.86%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$123.95 - $138.08 $120,975 - $134,766	-976 Reduced 2.04%	46,856 $6.37 Million
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $14,998 - $18,929	-135 Reduced 0.28%	47,832 $6.34 Million
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.4 Million - $1.65 Million	13,986 Added 41.16%	47,967 $5.47 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $53,689 - $59,930	533 Added 1.59%	33,981 $3.53 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $312,460 - $345,098	-2,853 Reduced 7.86%	33,448 $3.8 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $997,591 - $1.22 Million	-11,061 Reduced 23.35%	36,301 $4 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $369,223 - $443,006	-3,865 Reduced 7.54%	47,362 $4.59 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $421,663 - $469,821	-4,184 Reduced 7.55%	51,227 $5.58 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $396,932 - $467,212	-4,098 Reduced 6.89%	55,411 $5.61 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $2.15 Million - $2.52 Million	-22,576 Reduced 27.5%	59,509 $6.53 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $259,316 - $300,240	2,680 Added 3.38%	82,085 $7.94 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $86,453 - $104,494	-847 Reduced 1.06%	79,405 $8.63 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $1.45 Million - $1.77 Million	12,703 Added 18.81%	80,252 $9.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2.36 Million - $2.89 Million	20,402 Added 43.27%	67,549 $9.51 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $7,816 - $8,647	67 Added 0.14%	47,147 $5.57 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $51,837 - $61,019	490 Added 1.05%	47,080 $5.46 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $68,242 - $80,400	627 Added 1.36%	46,590 $5.58 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $52,815 - $57,553	-503 Reduced 1.08%	45,963 $5.03 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.01 Million - $2.45 Million	-21,982 Reduced 32.11%	46,466 $5.06 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $2.14 Million - $2.74 Million	-27,956 Reduced 29.0%	68,448 $6.26 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $398,530 - $582,759	6,344 Added 7.04%	96,404 $7.61 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $16,016 - $17,829	-204 Reduced 0.23%	90,060 $7.66 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $4.77 Million - $5.17 Million	58,287 Added 182.28%	90,264 $7.55 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $318,412 - $371,365	-4,369 Reduced 12.02%	31,977 $2.69 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $825,697 - $998,268	-12,469 Reduced 25.54%	36,346 $2.91 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $3.2 Million - $3.63 Million	48,815 New	48,815 $3.53 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Account

Gluskin Sheff & Assoc Inc Abbott Laboratories Transaction History